Ivana De Risi
Impact in
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 6
- Cutaneous Melanoma Detection and Management 3
-
- Melanoma and MAPK Pathways 3
- Extracellular vesicles in disease 3
- Co-authors
- Michele Guida (14 shared papers)Sabino Strippoli (12 shared papers)Simona De Summa (4 shared papers)Simona Serratì (4 shared papers)Letizia Porcelli (4 shared papers)Amalia Azzariti (4 shared papers)R. Fonte (4 shared papers)Gabriella Guida (2 shared papers)
In The Last Decade
Ivana De Risi
14 papers receiving 293 citations
Peers
Comparison fields: 5 of 56
- Immunology 117
- Oncology 151
- Cancer Research 68
- Molecular Biology 153
- Immunology and Allergy 13
Countries citing papers authored by Ivana De Risi
This map shows the geographic impact of Ivana De Risi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivana De Risi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivana De Risi more than expected).
Fields of papers citing papers by Ivana De Risi
This network shows the impact of papers produced by Ivana De Risi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivana De Risi. The network helps show where Ivana De Risi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivana De Risi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 116 | |
| 2 | 2021 | 37 | |
| 3 | 2022 | 21 | |
| 4 | 2021 | 19 | |
| 5 | 2022 | 19 | |
| 6 | 2019 | 19 | |
| 7 | 2023 | 18 | |
| 8 | 2020 | 13 | |
| 9 | 2021 | 9 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 6 | |
| 12 | 2020 | 4 | |
| 13 | 2024 | 4 | |
| 14 | 2025 | 2 |
About Ivana De Risi
Ivana De Risi is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Artificial Intelligence, having authored 14 papers that have together received 296 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (4 papers), Cutaneous Melanoma Detection and Management (3 papers), Melanoma and MAPK Pathways (3 papers), Extracellular vesicles in disease (3 papers), Nanoplatforms for cancer theranostics (2 papers) and Cell Image Analysis Techniques (2 papers). The work is most often cited by research in Immunology (117 citations), Oncology (151 citations), Cancer Research (68 citations), Molecular Biology (153 citations) and Immunology and Allergy (13 citations). Ivana De Risi has collaborated with scholars based in Italy and China. Frequent co-authors include Michele Guida, Sabino Strippoli, Simona De Summa, Simona Serratì, Letizia Porcelli, Amalia Azzariti, R. Fonte, Gabriella Guida, Rosa Maria Iacobazzi and Alessandra Quarta. Their work appears in journals such as Journal of Translational Medicine, Cancers, Journal of Experimental & Clinical Cancer Research, Scientific Reports and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.